Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Handbook of Experimental Pharmacology Année : 2017

Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases


The sigma-1 (σ1) receptor has been associated with regulation of intracellular Ca2+ homeostasis, several cellular signaling pathways, and inter-organelle communication, in part through its chaperone activity. In vivo, agonists of the σ1 receptor enhance brain plasticity, with particularly well-described impact on learning and memory. Under pathological conditions, σ1 receptor agonists can induce cytoprotective responses. These protective responses comprise various complementary pathways that appear to be differentially engaged according to pathological mechanism. Recent studies have highlighted the efficacy of drugs that act through the σ1 receptor to mitigate symptoms associated with neurodegenerative disorders with distinct mechanisms of pathogenesis. Here, we will review genetic and pharmacological evidence of σ1 receptor engagement in learning and memory disorders, cognitive impairment, and neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and Huntington's disease.
Fichier non déposé

Dates et versions

hal-01998711 , version 1 (29-01-2019)



Tangui Maurice, Nino Goguadze. Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases. Handbook of Experimental Pharmacology, 2017, 244, pp.81-108. ⟨10.1007/164_2017_15⟩. ⟨hal-01998711⟩
45 Consultations
0 Téléchargements



Gmail Facebook X LinkedIn More